Literature DB >> 17008822

The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials.

Richard H Weisler1, Andrew J Cutler, James C Ballenger, Robert M Post, Terence A Ketter.   

Abstract

Antiepileptic drugs (AEDs) have diverse psychotropic profiles. Some AEDs have proven to be efficacious in the treatment of mood disorders, especially bipolar disorder. Others are ineffective as primary treatments but may be useful adjuncts for mood disorders or comorbid conditions. Valproate (acute mania and mixed episodes), carbamazepine (acute mania and mixed episodes), and lamotrigine (maintenance to delay recurrence) have United States Food and Drug Administration indications for the treatment of bipolar disorder. This article provides an overview of data on the use of AEDs in bipolar disorder, including acute mania and depression, prophylaxis, and rapid cycling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17008822     DOI: 10.1017/s1092852900014917

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  5 in total

1.  Efficacy and Safety of Once- versus Twice-Daily Carbamazepine Extended-Release Capsules for the Treatment of Manic Symptoms in Patients with Bipolar I Disorder.

Authors:  Richard H Weisler; Amir H Kalali; Andrew J Cutler; Thomas D Gazda; Lawrence Ginsberg
Journal:  Psychiatry (Edgmont)       Date:  2008-03

2.  Varying uses of anticonvulsant medications.

Authors:  Elisa Cascade; Amir H Kalali; Richard H Weisler
Journal:  Psychiatry (Edgmont)       Date:  2008-06

3.  LICAVAL: combination therapy in acute and maintenance treatment of bipolar disorder.

Authors:  Rodolfo N Campos; Luis F Costa; Danielle S Bio; Márcio G Soeiro de Souza; Carla R L Garcia; Frederico N Demétrio; Doris H Moreno; Ricardo A Moreno
Journal:  Trials       Date:  2010-06-23       Impact factor: 2.279

4.  Safety of carbamazepine extended-release capsules used in combination with other psychotropic medications for the treatment of bipolar I disorder.

Authors:  Richard H Weisler; Amir H Kalali; Andrew J Cutler; Thomas D Gazda; Lawrence Ginsberg
Journal:  Psychiatry (Edgmont)       Date:  2008-05

5.  Chronic lamotrigine does not alter the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat: implications for the treatment of bipolar disorder.

Authors:  Ho-Joo Lee; Jagadeesh S Rao; Lisa Chang; Stanley I Rapoport; Richard P Bazinet
Journal:  Psychopharmacology (Berl)       Date:  2007-05-09       Impact factor: 4.415

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.